Amneal Pharmaceuticals, Inc. Stock Forecast

Sell candidate since Dec 12, 2024

The Amneal Pharmaceuticals, Inc. stock price fell by -2.22% on the last day (Thursday, 12th Dec 2024) from $8.10 to $7.92. During the last trading day the stock fluctuated 3.29% from a day low at $7.90 to a day high of $8.16. The price has fallen in 7 of the last 10 days and is down by -5.15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -104 thousand shares and in total, 597 thousand shares were bought and sold for approximately $4.73 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($7.99) are considered to be a "second chance" to get out. According to the fan-theory $6.82 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

AMRX Signals & Forecast

There are few to no technical positive signals at the moment. The Amneal Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.31 and $8.49. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, December 04, 2024, and so far it has fallen -10.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Amneal Pharmaceuticals, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.260 between high and low, or 3.29%. For the last week, the stock has had daily average volatility of 3.20%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AMRX) For The Upcoming Trading Day Of Friday 13th

For the upcoming trading day on Friday, 13th we expect Amneal Pharmaceuticals, Inc. to open at $7.99, and during the day (based on 14 day Average True Range), to move between $7.63 and $8.21, which gives a possible trading interval of +/-$0.293 (+/-3.70%) up or down from last closing price. If Amneal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.41% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $8.57, some $0.650 (8.21%) from the current price of $7.92, our system finds the risk reward not very attractive.

Is Amneal Pharmaceuticals, Inc. stock A Buy?

Amneal Pharmaceuticals, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.452 Sell Candidate Downgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on December 13, 2024 - $7.99 ( 0.88%).